Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2005-02-17 Interim / Quarterly Rep…
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
JUNE 30, 2004
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB/A' and is described as a quarterly report pursuant to the Securities Exchange Act of 1934 for the quarterly period ended June 30, 2004. It contains consolidated financial statements, management's discussion and analysis, disclosure controls, legal proceedings, changes in securities, and other substantive financial data. The presence of detailed financial statements and management discussion confirms it is a comprehensive interim financial report for a period shorter than a full fiscal year. The document is not a mere announcement or certification but contains actual financial data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2005-02-17 English
Interim / Quarterly Report 2005
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB/A' and is a quarterly report amendment for the period ended March 31, 2004. It contains detailed consolidated financial statements including balance sheets, statements of operations, cash flows, and shareholders' equity, as well as notes to the financial statements and management's discussion and analysis. The presence of comprehensive financial data and the quarterly period reference clearly identify this as an interim quarterly report. The document is not a brief announcement or certification but a full financial report. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2005-02-17 English
10KSB - AMENDED
Annual Report Classification · 100% confidence The document is titled 'FORM 10-KSB/A' and explicitly states it is an 'ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the fiscal year ended December 31, 2003. It includes detailed sections typical of an annual report such as Description of Business, Legal Proceedings, Management's Discussion and Analysis, Financial Statements, Executive Compensation, and other comprehensive disclosures. The length of the document (15,000 characters) and the detailed content confirm it is the full annual report, not just an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K).
2005-02-16 English
PRIMARY DOCUMENT
Director's Dealing
2005-02-15 English
PRIMARY DOCUMENT
Director's Dealing
2005-02-15 English
PRIMARY DOCUMENT
Director's Dealing
2005-02-15 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.